TLDR A new mouse model effectively mimics vitiligo for research and drug testing.
The study developed a mouse model for vitiligo that replicated key features of the disease, such as skin depigmentation and melanocyte loss, by activating endogenous autoreactive CD8+ T cells. This was achieved through the inoculation of B16F10 melanoma cells and depletion of CD4+ regulatory T cells. The model showed a 60-80% success rate in inducing depigmentation, with higher success in female mice, and was applicable to any C57BL/6 mouse strain. It provided a valuable tool for vitiligo research and drug discovery, allowing for the study of disease progression and potential therapeutic interventions.
43 citations
,
August 2018 in “Cell Stem Cell” Hoxc genes control hair growth through Wnt signaling.
60 citations
,
September 2004 in “Pediatric Dermatology” A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.
January 2012 in “heiDOK (Heidelberg University)” Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.
3 citations
,
June 2025 in “Stem Cell Research & Therapy” Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.
1 citations
,
January 2025 in “Frontiers in Pharmacology” Total glucosides of paeony can help treat skin conditions but need more research for clinical use.
26 citations
,
June 2024 in “Frontiers in Immunology” SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.
39 citations
,
June 2019 in “Toxins” Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.